Patient preference in the decision to place implantable cardioverter-defibrillators

Archives of Internal Medicine

Volumn 172, Issue 14, 2012, Pages 1104-1105

  Caverly, Tanner J ^a,b   Al Khatib, Sana M ^c,d   Kutner, Jean S ^a   Masoudi, Frederick A ^a,e,f   Matlock, Daniel D ^a,e,f  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e Colorado Cardiovascular Outcomes Research Institute ^*  (United States)

^f KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIAC PATIENT; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CROSS-SECTIONAL STUDY; DEFIBRILLATOR; HUMAN; MORTALITY; PATIENT PREFERENCE; PHYSICIAN; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; SOCIAL ASPECT; TREATMENT INDICATION;

ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; DEFIBRILLATORS, IMPLANTABLE; HUMANS; PATIENT PREFERENCE;

EID: 84864409994     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2012.2177     Document Type: Article

References (8)

1. Bardy GH, Lee KL, Mark DB, et al Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225-237. (Pubitemid 40110811)
2. Hunt SA, Abraham WT, Chin MH, et al. American College of Cardiology, American Heart Association Task Force on Practice Guidelines, American College of Chest Physicians, International Society for Heart and Lung Transplantation, Heart Rhythm Society: ACC/AHA 2005 Guideline Update for the diagnosis and management of chronic heart failure in the adult. Circulation. 2005; 112:e154-e235.
3. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA. 2006;295(7):809-818. (Pubitemid 43244308)
4. Goldenberg I, Moss AJ, Hall WJ, et al; Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Investigators. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Circulation. 2006;113(24):2810-2817. (Pubitemid 44305293)
5. Noyes K, Corona E, Zwanziger J, et al; Multicenter Automatic Defibrillator Implantation Trial II. Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II. Med Care. 2007;45 (5):377-385.
6. Matlock DD, Nowels CT, Masoudi FA, et al. Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study. Pacing Clin Electrophysiol. 2011;34(12):1634-1644.
7. Al-Khatib SM, Sanders GD, O'Brien SM, et al. Do physicians' attitudes toward implantable cardioverter defibrillator therapy vary by patient age, gender, or race? Ann Noninvasive Electrocardiol. 2011;16(1):77-84.
8. Barry MJ, Edgman-Levitan S. Shared decision making: pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780-781.